Calamos Advisors LLC purchased a new stake in Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 375,000 shares of the company’s stock, valued at approximately $6,915,000.
Separately, Tuttle Capital Management LLC acquired a new stake in Translational Development Acquisition in the fourth quarter valued at approximately $461,000.
Translational Development Acquisition Trading Up 0.1 %
NASDAQ TDACU opened at $10.06 on Wednesday. Translational Development Acquisition Corp. has a fifty-two week low of $10.00 and a fifty-two week high of $10.06.
About Translational Development Acquisition
Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.
Featured Stories
- Five stocks we like better than Translational Development Acquisition
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- What Are Dividend Achievers? An Introduction
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Investing in the High PE Growth Stocks
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Want to see what other hedge funds are holding TDACU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report).
Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
